{"id":"W2061612454","doi":"10.1177/1753465810371107","title":"Emerging therapies in cystic fibrosis","year":2010,"lang":"en","type":"review","venue":"Therapeutic Advances in Respiratory Disease","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Bayer Canada; Gilead Sciences","keywords":"Cystic fibrosis; Medicine; Cystic fibrosis transmembrane conductance regulator; Clinical trial; Life expectancy; Disease; Targeted therapy; Immunology; Intensive care medicine; Bioinformatics; Internal medicine; Population","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008406707,0.001070365,0.001240026,0.002526734,0.0004565017,0.0008951545,0.0008799349,0.001703076,0.005949064],"category_scores_gemma":[0.0007420159,0.0002565254,0.0006257122,0.001725673,0.0007630098,0.001703618,0.0009572222,0.003195105,0.00327739],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007563708,"about_ca_system_score_gemma":0.0007802827,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001061161,"about_ca_topic_score_gemma":0.002541639,"domain_scores_codex":[0.9996632,0.00006632907,0.00003767595,0.00003992328,0.0001605541,0.00003234764],"domain_scores_gemma":[0.9996947,0.00015382,0.00003324996,0.00001343351,0.00007458858,0.00003016181],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006813132,0.0001183457,0.0001213587,0.008014289,0.00005001198,0.0004028402,0.0001113535,0.0003131851,0.002583741,0.008523266,0.04558877,0.9341046],"study_design_scores_gemma":[0.00002855571,0.00008039769,0.0003515377,0.002048851,0.00002458784,0.001190272,0.00004653865,0.00005928556,0.0003015436,0.002822005,0.9930359,0.0000105825],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00009306998,0.9966916,0.0001403559,0.0004031681,0.0003580294,0.00000989612,0.00001014352,0.000007638418,0.002286061],"genre_scores_gemma":[0.0006605334,0.9962997,0.0004090377,0.0005406163,0.000301662,0.00001549573,0.00002872535,0.000002015951,0.001742268],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005949064,"threshold_uncertainty_score":0.01990157,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04226880032122836,"score_gpt":0.4069944207173359,"score_spread":0.3647256203961075,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}